Pangaea Oncology, S.A. (BME:PANG)

Pangaea Oncology Revenue

Pangaea Oncology had revenue of 7.55M EUR in the half year ending June 30, 2024, with 124.19% growth. This brings the company's revenue in the last twelve months to 14.35M, up 122.29% year-over-year. In the year 2023, Pangaea Oncology had annual revenue of 9.95M with 49.12% growth.

• Revenue (ttm): 14.35M
• Revenue Growth: +122.29%
• P/S Ratio: 4.07
• Revenue / Employee: 90.28K
• Employees: 149
• Market Cap: 58.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.95M	3.28M	49.12%
Dec 31, 2022	6.68M	-32.46K	-0.48%
Dec 31, 2021	6.71M	531.99K	8.61%
Dec 31, 2020	6.18M	671.42K	12.20%
Dec 31, 2019	5.50M	-175.96K	-3.10%